Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564275 · ClinicalTrials.gov registry record · NA
Proton Boost in Prostate Cancer
A NA study of Cancer of the Prostate, sponsored by University of Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03564275: Active NA study of Cancer of the Prostate, sponsored by University of Cincinnati.
NCT03564275 is a NA study of Cancer of the Prostate that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 10 participants, below the 4,932-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03564275, a NA study of Cancer of the Prostate, is active but no longer recruiting, sponsored by University of Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study uses photon radiation with a proton boost to treat prostate cancer. The purpose of this study is to determine if proton therapy as a boost following photon intensity modulated radiation therapy (IMRT) produces decreased toxicity as compared to conventional photon IMRT alone in the treatment of prostate cancer. Our secondary objective is to determine the effectiveness of this treatment regimen. Effectiveness will be determined by length of time to progression or recurrence of disease and overall survival. Patients on this study will be treated with a course of photon radiation therapy followed by a boost course of proton radiation.
Primary Outcome
Common Terminology Criteria for Adverse Events - Hematuria Scale - 1(least severe) - 5 (most severe)
Conditions Studied
Interventions
- RADIATION Proton Boost
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2033-04 |
| Phase | NA |
What the registry record for NCT03564275 still lists
NCT03564275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 4,932-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Cancer of the Prostate appearing as the primary indexed condition, and to 1 intervention - of which Proton Boost is the first listed.
NCT03564275 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03564275 about?
NCT03564275 is a clinical study titled "Proton Boost in Prostate Cancer". This study uses photon radiation with a proton boost to treat prostate cancer. The purpose of this study is to determine if proton therapy as a boost following photon intensity modulated radiation therapy (IMRT) produces decreased toxicity as compared to conventional photon IMRT alone in the treatme...
What is the current status of trial NCT03564275?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-04-16. Estimated completion is 2033-04.
What conditions does trial NCT03564275 study?
This clinical trial studies the following conditions: Cancer of the Prostate.
What interventions are being tested in trial NCT03564275?
The interventions under investigation include: Proton Boost (RADIATION).
Who is sponsoring clinical trial NCT03564275?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03564275 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of the Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03564275's enrollment target sits among peer trials
10 12th of 11 the lowest of 11 other Cancer of the Prostate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer of the Prostate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigation of Impact of AI on Prostate Cancer Workflow
RECRUITING · NA
-
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
RECRUITING · NA
-
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
COMPLETED · NA
-
MRI/Ultrasound Fusion Guided Prostate Cryotherapy
RECRUITING
-
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI